leisure time -WSS

leisure time

author：hotspot 2025-08-08 05:32:53 - browse：729

A sign of The Cigna Group in front of trees with orange and green leaves — insurance overage from STAT — Joe Buglewicz/Bloomberg

Cigna and Humana are in discussions to merge, a potential move that would create a health insurance and prescription drug benefits titan with approximately $300 billion of annual revenue.

A proposed transaction would almost certainly prompt a close review from antitrust enforcers at the Department of Justice and the Federal Trade Commission. A merged Cigna-Humana would further consolidate the market for pharmacy benefit managers. PBMs are companies that serve as the controversial middlemen of drug pricing negotiations, and of the four largest, two are owned by Cigna and Humana.

The Wall Street Journal first reported the talks between Cigna and Humana on Wednesday, citing sources close to the situation. Wendell Potter, a health insurance whistleblower who used to work at Cigna, also wrote about merger discussions between Cigna and Humana on his blog Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： A Q&A with Gavi’s Seth Berkley on vaccines, Covid, and more

focus

WSS

7 more heat

ASCO: Palliative care found as helpful given virtually as in person

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

Study identifies new proteins linked to dementia risk 25 years later

Awakening the world to the whoosh: A patient's crusade

Hospitals struggle to profit from CAR

leisure time

leisure time

hotspot

United colonoscopy coverage change 'may cost lives,' doctors say

7 more heat

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

United colonoscopy coverage change 'may cost lives,' doctors say

Innovation in antibiotics is ailing. 'Brain drain' may kill it

The high cost of giving birth even with insurance

Vir antibody drug aimed at influenza A fails in clinical trial

knowledge

Affordable Connectivity Program vital to health care, experts say

Ultragenyx gene therapy for rare liver ailment succeeds in late

ASCO: Palliative care found as helpful given virtually as in person

7 more heat

Change Healthcare can notify patients about the breach, HHS says

Judge rejects Trump's request to move Stormy Daniels hush

Wikipedia

focus

focus

focus